1. Home
  2. EYPT vs LDI Comparison

EYPT vs LDI Comparison

Compare EYPT & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • LDI
  • Stock Information
  • Founded
  • EYPT 1987
  • LDI 2010
  • Country
  • EYPT United States
  • LDI United States
  • Employees
  • EYPT N/A
  • LDI N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • LDI Finance: Consumer Services
  • Sector
  • EYPT Industrials
  • LDI Finance
  • Exchange
  • EYPT Nasdaq
  • LDI Nasdaq
  • Market Cap
  • EYPT 967.4M
  • LDI 954.8M
  • IPO Year
  • EYPT 2005
  • LDI 2021
  • Fundamental
  • Price
  • EYPT $11.76
  • LDI $3.09
  • Analyst Decision
  • EYPT Strong Buy
  • LDI Sell
  • Analyst Count
  • EYPT 5
  • LDI 3
  • Target Price
  • EYPT $27.40
  • LDI $3.00
  • AVG Volume (30 Days)
  • EYPT 1.4M
  • LDI 7.2M
  • Earning Date
  • EYPT 11-05-2025
  • LDI 11-06-2025
  • Dividend Yield
  • EYPT N/A
  • LDI N/A
  • EPS Growth
  • EYPT N/A
  • LDI N/A
  • EPS
  • EYPT N/A
  • LDI N/A
  • Revenue
  • EYPT $51,898,000.00
  • LDI $1,124,074,000.00
  • Revenue This Year
  • EYPT N/A
  • LDI $20.83
  • Revenue Next Year
  • EYPT N/A
  • LDI $17.30
  • P/E Ratio
  • EYPT N/A
  • LDI N/A
  • Revenue Growth
  • EYPT 2.99
  • LDI 27.06
  • 52 Week Low
  • EYPT $3.91
  • LDI $1.01
  • 52 Week High
  • EYPT $14.91
  • LDI $5.05
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 42.93
  • LDI 48.70
  • Support Level
  • EYPT $11.15
  • LDI $3.36
  • Resistance Level
  • EYPT $12.47
  • LDI $3.52
  • Average True Range (ATR)
  • EYPT 0.68
  • LDI 0.26
  • MACD
  • EYPT -0.08
  • LDI -0.02
  • Stochastic Oscillator
  • EYPT 23.37
  • LDI 34.40

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About LDI loanDepot Inc.

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.

Share on Social Networks: